Peng-Jun Lu1, Alissa O'Halloran2, Helen Ding2, Jennifer L Liang3, Walter W Williams2. 1. Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia. Electronic address: lhp8@cdc.gov. 2. Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia. 3. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.
Abstract
INTRODUCTION: The Advisory Committee on Immunization Practices recommends a single dose of tetanus, diphtheria, and acellular pertussis vaccine (Tdap) for adults followed by tetanus and diphtheria toxoids (Td) booster doses every 10 years thereafter. This study assessed recent Td and Tdap vaccination among adult populations. METHODS: The 2013 Behavioral Risk Factor Surveillance System data were analyzed in 2015 to assess Td and Tdap vaccination coverage among adults at national and state levels. Multivariable logistic regression and predictive marginal models were performed to identify factors independently associated with vaccination. RESULTS: Overall, national vaccination coverage among adults aged ≥18 years for Td was 57.5% and for Tdap was 28.9%. Among states, Td vaccination coverage ranged from 47.8% in Nevada to 73.1% in Minnesota, and Tdap coverage ranged from 17.7% in Mississippi to 47.6% in Minnesota. Characteristics independently associated with an increased likelihood of Tdap vaccination among adults aged ≥18 years were younger age; being female; American Indian/Alaska Native race; being never married; higher education; not being in the workforce; reporting a household income ≥$75,000; living in the West or Midwest U.S.; reporting excellent, very good, good, or fair health; having health insurance; having a healthcare provider; having a routine checkup in the previous year; receipt of influenza vaccination in the previous year; and having ever received pneumococcal vaccination. CONCLUSIONS: By 2013, Td and Tdap vaccination coverage were 57.5% and 28.9%, respectively. Coverage varied by state. Implementation of evidence-based programs is needed to improve Td and Tdap vaccination levels among adult populations. Published by Elsevier Inc.
INTRODUCTION: The Advisory Committee on Immunization Practices recommends a single dose of tetanus, diphtheria, and acellular pertussis vaccine (Tdap) for adults followed by tetanus and diphtheria toxoids (Td) booster doses every 10 years thereafter. This study assessed recent Td and Tdap vaccination among adult populations. METHODS: The 2013 Behavioral Risk Factor Surveillance System data were analyzed in 2015 to assess Td and Tdap vaccination coverage among adults at national and state levels. Multivariable logistic regression and predictive marginal models were performed to identify factors independently associated with vaccination. RESULTS: Overall, national vaccination coverage among adults aged ≥18 years for Td was 57.5% and for Tdap was 28.9%. Among states, Td vaccination coverage ranged from 47.8% in Nevada to 73.1% in Minnesota, and Tdap coverage ranged from 17.7% in Mississippi to 47.6% in Minnesota. Characteristics independently associated with an increased likelihood of Tdap vaccination among adults aged ≥18 years were younger age; being female; American Indian/Alaska Native race; being never married; higher education; not being in the workforce; reporting a household income ≥$75,000; living in the West or Midwest U.S.; reporting excellent, very good, good, or fair health; having health insurance; having a healthcare provider; having a routine checkup in the previous year; receipt of influenza vaccination in the previous year; and having ever received pneumococcal vaccination. CONCLUSIONS: By 2013, Td and Tdap vaccination coverage were 57.5% and 28.9%, respectively. Coverage varied by state. Implementation of evidence-based programs is needed to improve Td and Tdap vaccination levels among adult populations. Published by Elsevier Inc.
Authors: Kendra L Schwartz; Anne Victoria Neale; Justin Northrup; Joseph Monsur; Divya A Patel; Rodrigo Tobar; Pascale M Wortley Journal: J Gen Intern Med Date: 2006-04 Impact factor: 5.128
Authors: S J Rolnick; E D Parker; J D Nordin; B D Hedblom; F Wei; T Kerby; J M Jackson; A L Crain; G Euler Journal: Vaccine Date: 2013-06-24 Impact factor: 3.641
Authors: Fang Xu; Tebitha Mawokomatanda; David Flegel; Carol Pierannunzi; William Garvin; Pranesh Chowdhury; Simone Salandy; Carol Crawford; Machell Town Journal: MMWR Surveill Summ Date: 2014-10-24
Authors: David E Nelson; Shayne Bland; Eve Powell-Griner; Richard Klein; Henry E Wells; Gary Hogelin; James S Marks Journal: JAMA Date: 2002 May 22-29 Impact factor: 56.272
Authors: Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; Carolyn B Bridges; David K Kim; Tamara Pilishvili; Craig M Hales; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-02-06 Impact factor: 17.586
Authors: Liliana Sánchez-González; Alfonso Rodriguez-Lainz; Alissa O'Halloran; Ali Rowhani-Rahbar; Jennifer L Liang; Peng-Jun Lu; Peter M Houck; Stephane Verguet; Walter W Williams Journal: J Community Health Date: 2017-06
Authors: Alissa C O'Halloran; Peng-Jun Lu; Sarah A Meyer; Walter W Williams; Pamela K Schumacher; Aaron L Sussell; Jan E Birdsey; Winifred L Boal; Marie Haring Sweeney; Sara E Luckhaupt; Carla L Black; Tammy A Santibanez Journal: Am J Prev Med Date: 2017-11-21 Impact factor: 5.043
Authors: Jacob Lee; Jung-Hyun Choi; Seong-Heon Wie; Sun Hee Park; Su-Mi Choi; Mi Suk Lee; Tae Hyong Kim; Hyo-Jin Lee; Jin Han Kang Journal: J Korean Med Sci Date: 2019-01-16 Impact factor: 2.153